Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients
Condition(s):Systemic Lupus ErythematosusLast Updated:April 8, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):Systemic Lupus ErythematosusLast Updated:April 8, 2021Recruiting
Condition(s):Atherosclerosis Coronary Artery With Angina Pectoris; Atheroscleroses, Coronary; Atherosclerotic Plaque; Thin-cap fIbroatheroma; AtherosclerosisLast Updated:April 8, 2021Not yet recruiting
Condition(s):COVID-19Last Updated:April 8, 2021Not yet recruiting
Condition(s):EmergenciesLast Updated:April 8, 2021Recruiting
Condition(s):Anesthesia for Cardio or Neurovascular Surgery or ProcedureLast Updated:April 6, 2021Recruiting
Condition(s):Diabetic Peripheral Neuropathic PainLast Updated:April 9, 2021Not yet recruiting
Condition(s):Lumbar Disc Prolapse With RadiculopathyLast Updated:April 6, 2021Not yet recruiting
Condition(s):GERDLast Updated:April 5, 2021Not yet recruiting
Condition(s):HypertensionLast Updated:April 5, 2021Recruiting
Condition(s):Pneumococcal DiseaseLast Updated:April 5, 2021Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.